Answers to these questions may help guide obesity treatment, but may also inform future areas of research as we learn more about the beneficial effects of GLP-1 receptor agonists such as semaglutide, Ortiz-Pujols said
The Oral segment is expected to witness the fastest CAGR of 10.2% from 2026 to 2033, driven by growing patient preference for non-injectable treatment options and advancements in oral peptide delivery technologies
The dual-action formula of Zepbound may help target weight loss and metabolic health more effectively for certain individuals
Patients who tolerate a medication well enough to continue taking it are a self-selected group
According to him, the most credible differentiation strategies include: Novel receptor pharmacology: Ecnoglutide's biased agonism produces markedly lower rates of GI side effects and discontinuation
Vitamin B12 is essential for keeping your brain, nervous system, and red blood cells healthy